Ribometrix raises $30 million to target RNA with small molecules
Tuesday, November 13, 2018 - 01:20
in Biology & Nature
The startup hopes that blocking the RNA encoding undruggable proteins will lead to new treatments for cancer, neurodegenerative diseases, and more